Teva, Others in Talks With DOJ to End Generic Drug Probe

The video discusses allegations of price-fixing in the generic drug market, involving talks between companies and the Justice Department. The investigation has faced challenges due to a lack of credible witnesses and impending statute of limitations. Companies are considering deferred prosecution agreements to avoid criminal charges, which would allow them to continue working with government programs like Medicaid. The video also highlights the potential impact of these agreements on civil lawsuits and other legal issues, including the opioid epidemic.

What potential consequences could the companies face if found guilty of price fixing?

How might settling with the DOJ affect the civil case against the companies?